Review
doi: 10.1016/j.blre.2007.01.002.
Epub 2007 Mar 26.
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
Affiliations
- PMID: 17367905
- DOI: 10.1016/j.blre.2007.01.002
Item in Clipboard
Review
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
Blood Rev.
2007 Sep.
Abstract
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are asymptomatic disorders characterized by monoclonal plasma cell proliferation in the bone marrow in the absence of end-organ damage. Updated diagnostic criteria for these disorders, risk-stratification models to determine prognosis, and the current management of these two entities are discussed in this review.
Similar articles
-
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.Clin Cancer Res. 2002 Jul;8(7):2210-6. Clin Cancer Res. 2002. PMID: 12114422
-
MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management.Hematology Am Soc Hematol Educ Program. 2005:340-5. doi: 10.1182/asheducation-2005.1.340. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304401
-
Neuromuscular disorders associated with paraproteinemia.Phys Med Rehabil Clin N Am. 2008 Feb;19(1):61-79, vi. doi: 10.1016/j.pmr.2007.10.005. Phys Med Rehabil Clin N Am. 2008. PMID: 18194750 Review.
-
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.Br J Haematol. 2003 Jun;121(5):749-57. Br J Haematol. 2003. PMID: 12780789
-
Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.Br J Haematol. 2007 Dec;139(5):730-43. doi: 10.1111/j.1365-2141.2007.06873.x. Br J Haematol. 2007. PMID: 18021088 Review.
Cited by
-
Development of early treatment strategies for high-risk myeloma precursor disease in the future.Semin Hematol. 2011 Jan;48(1):66-72. doi: 10.1053/j.seminhematol.2010.11.009. Semin Hematol. 2011. PMID: 21232660 Free PMC article. Review.
-
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.J Mol Diagn. 2015 Nov;17(6):669-78. doi: 10.1016/j.jmoldx.2015.06.006. Epub 2015 Sep 30. J Mol Diagn. 2015. PMID: 26433312 Free PMC article.
-
Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition.Leukemia. 2014 Oct;28(10):2112-5. doi: 10.1038/leu.2014.193. Epub 2014 Jun 12. Leukemia. 2014. PMID: 24919808 No abstract available.
-
Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma.Semin Hematol. 2011 Jan;48(1):4-12. doi: 10.1053/j.seminhematol.2010.11.003. Semin Hematol. 2011. PMID: 21232653 Free PMC article. Review.
-
Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future.Clin Lymphoma Myeloma Leuk. 2010 Aug;10(4):248-57. doi: 10.3816/CLML.2010.n.053. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20709660 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
